Diligence memo · auto-generated · as of July 2, 2026

Rennova Health, Inc.

Rennova Health, Inc. has raised $120M over 37 rounds; too few niche peers to rank its valuation yet.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Rennova Health, Inc. operates in Hospitals and Physicians, based in WEST PALM BEACH.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Rennova Health, Inc. has raised $120M in disclosed capital across 37 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $30M on 2020-08-31.

Most recent recorded round closed around 2022-03-11.

Filings read as a recurring offering program rather than a clean venture-stage ladder — interpret stage labels and step-ups with that in mind.

Valuation (modeled)modeled

Provath models Rennova Health, Inc. at approximately $19M (range $3.7M–$53M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Too few comparable companies in this niche to rank the valuation fairly yet.

Financing rhythm & timingmixed

Historic cadence: a new round about every 3 months.

Last raise 4.3 yr ago; this sector typically re-raises about every 12 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.5× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 96% of Hospitals and Physicians peers (599 compared).

Modeled value ranks above 46% of those peers.

Closest niche peers: Chinese American IPA, Inc., Frontier Network Inc.

Peoplefiled

22 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.

Recurring-offering pattern: stage-based valuation has lower applicability.